1253 Results

People

  1. Motzer
    Motzer
  2. Kingham
    Kingham
  3. Hudis
    Hudis
  4. Abou-Alfa
    Abou-Alfa
  5. Horwitz
    Horwitz
  6. Zelenetz
    Zelenetz
  7. Kris
    Kris
  8. Perales
    Perales
  9. Aghajanian
    Aghajanian
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (680)
  2. Solid Tumor Oncology Division (431)
  3. Hematologic Malignancies, Division of (230)
  4. Surgery (201)
  5. Center for Hematologic Malignancies (186)
  6. Survivorship Research (182)
  7. Population Sciences Research Program (170)
  8. Epidemiology and Biostatistics (122)
  9. Center for Pancreatic Cancer Research (110)
  10. Genitourinary Oncology Service (109)
  1. "multicenter study"
Formats
  1. Journal Article (1219)
  2. Research Letter (12)
  3. Conference Paper (7)
  4. Correspondence (6)
  5. Review (5)
  6. Guidelines (2)
  7. Editorial (1)
  8. Miscellaneous (1)
Groups
  1. Department of Medicine (680)
  2. Solid Tumor Oncology Division (431)
  3. Hematologic Malignancies, Division of (230)
  4. Surgery (201)
  5. Center for Hematologic Malignancies (186)
  6. Survivorship Research (182)

More Groups

People
  1. Robert Motzer (47)
  2. T Peter Kingham (31)
  3. Clifford Hudis (19)
  4. Andrew Zelenetz (18)
  5. Ghassan Abou-Alfa (18)
  6. Steven Horwitz (18)

More People

Years
  1. 2025 (86)
  2. 2024 (191)
  3. 2023 (130)
  4. 2022 (83)
  5. 2021 (50)
  6. 2020 (63)

More Years

Publications
  1. Journal of Clinical Oncology (118)
  2. Lancet Oncology (57)
  3. New England Journal of Medicine (56)
  4. Clinical Cancer Research (46)
  5. Blood (44)
  6. Cancer (36)

More Publications

Publishers
  1. Elsevier Inc. (152)
  2. Elsevier Science, Inc. (137)
  3. American Society of Clinical Oncology (124)
  4. Springer (84)
  5. Oxford University Press (79)
  6. Wiley Blackwell (71)

More Publishers

Results (1253)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pembrolizumab plus lenvatinib as first-line therapy for advanced non-clear-cell renal cell carcinoma (KEYNOTE-B61): A single-arm, multicentre, phase 2 trial
    Journal Article

    Albiges, L.; Gurney, H.; Atduev, V.; Suarez, C.; Climent, M. A.; Pook, D.; Tomczak, P.; Barthelemy, P.; Lee, J. L.; Stus, V.; more...
    Lancet Oncology (2023)

    Fulltext@MSK | Save
  • Brentuximab vedotin with AVD for stage II–IV HIV-related Hodgkin lymphoma (AMC 085): Phase 2 results from an open-label, single arm, multicentre phase 1/2 trial
    Journal Article

    Rubinstein, P. G.; Moore, P. C.; Bimali, M.; Lee, J. Y.; Rudek, M. A.; Chadburn, A.; Ratner, L.; Henry, D. H.; Cesarman, E.; DeMarco, C. E.; more...
    The Lancet Haematology (2023)

    Fulltext@MSK | Save
  • Quality-of-life, concerns, and treatment priorities in patients with cancer-related ischemic stroke: A prospective survey study
    Journal Article

    Dawod, J.; Abbasi, M. H.; Navi, B. B.; Kasner, S. E.
    Journal of Stroke & Cerebrovascular Diseases (2023)

    Fulltext@MSK | Save
  • Pirtobrutinib in covalent Bruton tyrosine kinase inhibitor pretreated mantle-cell lymphoma
    Journal Article

    Wang, M. L.; Jurczak, W.; Zinzani, P. L.; Eyre, T. A.; Cheah, C. Y.; Ujjani, C. S.; Koh, Y.; Izutsu, K.; Gerson, J. N.; Flinn, I.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: A cohort study
    Journal Article

    Elkrief, A.; Alessi, J. M. V.; Ricciuti, B.; Brown, S.; Rizvi, H.; Preeshagul, I. R.; Wang, X.; Pecci, F.; Di Federico, A.; Lamberti, G.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • ComBat harmonization for MRI radiomics: Impact on nonbinary tissue classification by machine learning
    Journal Article

    Leithner, D.; Nevin, R. B.; Gibbs, P.; Weber, M.; Otazo, R.; Vargas, H. A.; Mayerhoefer, M. E.
    Investigative Radiology (2023)

    Fulltext@MSK | Save
  • Extensive versus focal lymphovascular invasion in squamous cell carcinoma of the cervix: A comprehensive international, multicenter, retrospective clinicopathologic study
    Journal Article

    Praiss, A. M.; Allison, D.; Tessier-Cloutier, B.; Flynn, J.; Iasonos, A.; Hoang, L.; Patrichi, A.; Terinte, C.; Pesci, A.; Mateoiu, C.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Efficacy, safety, and cost of mobilization strategies in multiple myeloma: A prospective, observational study
    Research Letter

    Dhakal, B.; Zhang, M. J.; Burns, L. J.; Tang, X.; Meyer, C.; Mau, L. W.; Nooka, A. K.; Stadtmauer, E.; Micallef, I. N.; McGuirk, J.; more...
    Haematologica (2023)

    Fulltext@MSK | Save
  • Survival by depth of response and efficacy by International Metastatic Renal Cell Carcinoma Database Consortium subgroup with lenvatinib plus pembrolizumab versus sunitinib in advanced renal cell carcinoma: Analysis of the phase 3 randomized CLEAR Study
    Journal Article

    Grünwald, V.; Powles, T.; Kopyltsov, E.; Kozlov, V.; Alonso-Gordoa, T.; Eto, M.; Hutson, T.; Motzer, R.; Winquist, E.; Maroto, P.; more...
    European Urology Oncology (2023)

    Fulltext@MSK | Save
  • Impact of liver cirrhosis and portal hypertension on minimally invasive limited liver resection for primary liver malignancies in the posterosuperior segments: An international multicenter study
    Journal Article

    Lim, C.; Scatton, O.; Wu, A. G. R.; Zhang, W.; Hasegawa, K.; Cipriani, F.; Sijberden, J.; Aghayan, D. L.; Siow, T. F.; Dokmak, S.; more...
    European Journal of Surgical Oncology (2023)

    Fulltext@MSK | Save